Effect of complete percutaneous revascularization on improving long-term outcomes of patients with chronic total

Zeya Li1, Ziru Zhou2, Lei Guo2

  • 1Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Xuan Wu District, Beijing 100050, China.

Insights

Complete percutaneous coronary intervention (PCI) significantly reduces major adverse cardiovascular events (MACEs) and unstable angina in patients with chronic total occlusion (CTO) and multi-vessel disease (MVD). This approach offers improved long-term prognosis compared to incomplete PCI or optimal medical treatment alone.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Limited comparative data exist for clinical outcomes of complete versus incomplete percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) and multi-vessel disease (MVD).
  • Understanding the impact of PCI completeness is crucial for optimizing treatment strategies in complex coronary artery disease.

Purpose of the Study:

  • To compare the clinical outcomes of complete versus incomplete PCI in patients diagnosed with both CTO and MVD.
  • To evaluate the long-term efficacy of different revascularization strategies, including optimal medical treatment (OMT), incomplete PCI, and complete PCI.

Main Methods:

  • A cohort of 558 patients with CTO and MVD was analyzed, stratified into OMT (n=86), incomplete PCI (n=327), and complete PCI (n=145) groups.
  • Propensity score matching (PSM) was employed for sensitivity analysis comparing complete and incomplete PCI groups.
  • The primary endpoint was major adverse cardiovascular events (MACEs); unstable angina served as the secondary outcome.

Main Results:

  • At a median 21-month follow-up, complete PCI demonstrated significantly lower rates of MACEs (20.0%) and unstable angina (10.3%) compared to incomplete PCI (30.6% MACEs, 19.3% unstable angina) and OMT (43.0% MACEs, 24.4% unstable angina).
  • Complete PCI was independently associated with reduced MACE risk versus OMT (adjusted HR=2.00) and incomplete PCI (adjusted HR=1.58).
  • PSM confirmed these findings, showing significantly lower MACE (20.5% vs 32.6%) and unstable angina (10.7% vs 20.5%) rates in the complete PCI group compared to the incomplete PCI group.

Conclusions:

  • Complete PCI significantly reduces the long-term risk of MACEs and unstable angina in patients with CTO and MVD when compared to incomplete PCI and OMT.
  • Achieving complete revascularization, encompassing both CTO and non-CTO lesions, appears to improve patient prognosis in this complex population.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
15
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
14
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
18